Lung cancer resistance: the key is glucose
Cancers are not only made of tumour cells. In fact, as they grow, they develop an entire cellular ecosystem within and around them. This “tumour microenvironment” is made… read more.
Cancers are not only made of tumour cells. In fact, as they grow, they develop an entire cellular ecosystem within and around them. This “tumour microenvironment” is made… read more.
Interview and article by Christine Clark. The results of the recent controlled trial of ivermectin for covid-19 in Colombia suggest that both ivermectin and control groups received ivermectin,… read more.
Interview and article by Christine Clark Dr David Scheim explains how multiple protocol violations and widespread use of over-the-counter ivermectin could have compromised the results of a recent… read more.
The Israel Ministry of Health (MoH), Pfizer Inc. and BioNTech SE announced real-world evidence demonstrating dramatically lower incidence rates of COVID-19 disease in individuals fully vaccinated with the… read more.
Interview and article by Christine Clark Dr David Scheim explains how the original analysis factored out confounders and showed a 74% reduction in deaths at 30 days as… read more.
Interview and article by Christine Clark Further analysis of results from Peru has now shown that systematic treatment of the population for covid-19 with ivermectin resulted in a… read more.
The Medicines Health Regulatory Authority (MHRA) and European Medicines Agency (EMA) reaffirmed the benefits of COVID-19 Vaccine AstraZeneca continue to far outweigh the risks.
Allarity Therapeutics A/S announced that it has enrolled the first patient in its European Phase II clinical trial of Ixempra (ixabepilone) for the treatment of metastatic breast cancer.
Research from Queen Mary University of London has concluded that there is convincing evidence that type 2 diabetes is associated with an increased risk of Parkinson’s disease. The… read more.
Lupin Pharma, a subsidiary of global pharma major Lupin Ltd, announced a partnership with Endoceutics, a women’s health focused innovative Canadian biotech company, to commercialize Intrarosa in Canada.
An analysis of several large studies involving participants from more than 60 countries, spearheaded by researchers from McMaster University, has found that eating oily fish regularly can help… read more.
Melinta Therapeutics, LLC announced that the FDA has approved Kimyrsa (oritavancin) for the treatment of adult patients with acute bacterial skin and skin structure infections (ABSSSI) caused by… read more.